Progesterone for the prevention of preterm birth in twin pregnancy (STOPPIT): a randomised, double-blind, placebo-controlled study and meta-analysis

被引:192
作者
Norman, Jane E. [1 ]
Mackenzie, Fiona [2 ]
Owen, Philip [2 ]
Mactier, Helen [2 ]
Hanretty, Kevin [3 ]
Cooper, Sarah [4 ]
Calder, Andrew
Mires, Gary [5 ]
Danielian, Peter [6 ]
Sturgiss, Stephen [7 ]
MacLennan, Graeme [8 ]
Tydeman, Graham [9 ]
Thornton, Steven [10 ]
Martin, Bill [12 ]
Thornton, James G. [11 ]
Neilson, James P. [13 ]
Norrie, John [14 ]
机构
[1] Univ Edinburgh, Ctr Reprod Biol, Queens Med Res Inst, Edinburgh EH16 4TJ, Midlothian, Scotland
[2] Princess Royal Matern, Glasgow, Lanark, Scotland
[3] Univ Glasgow, Glasgow, Lanark, Scotland
[4] Royal Infirm, Simpson Ctr Reprod, Edinburgh, Midlothian, Scotland
[5] Univ Dundee, Div Clin & Populat Sci & Educ, Dundee, Scotland
[6] Aberdeen Matern Hosp, Aberdeen, Scotland
[7] Royal Victoria Infirm, Newcastle Upon Tyne, Tyne & Wear, England
[8] Univ Aberdeen, Ctr Healthcare Randomised Trials, Aberdeen, Scotland
[9] Forth Pk Matern Hosp, Kirkcaldy, Scotland
[10] Univ Warwick, Warwick Med Sch, Warwick, England
[11] Nottingham Univ Hosp NHS Trust, Nottingham, England
[12] Birmingham Womens Hosp, Birmingham, W Midlands, England
[13] Liverpool Womens Hosp, Liverpool, Merseyside, England
[14] Univ Glasgow, Roberston Ctr Biostat, Glasgow, Lanark, Scotland
关键词
17-ALPHA-HYDROXYPROGESTERONE CAPROATE; PREMATURITY; TRIAL; WOMEN; RISK;
D O I
10.1016/S0140-6736(09)60947-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Women with twin pregnancy are at high risk for spontaneous preterm delivery. Progesterone seems to be effective in reducing preterm birth in selected high-risk singleton pregnancies, albeit with no significant reduction in perinatal mortality and little evidence of neonatal benefit. We investigated the use of progesterone for prevention of preterm birth in twin pregnancy. Methods In this double-blind, placebo-controlled trial, 500 women with twin pregnancy were recruited from nine UK National Health Service clinics specialising in the management of twin pregnancy. Women were randomised, by permuted blocks of randomly mixed sizes, either to daily vaginal progesterone gel 90 mg (n=250) or to placebo gel (n=250) for 10 weeks from 24 weeks' gestation. All study personnel and participants were masked to treatment assignment for the duration of the study. The primary outcome was delivery or intrauterine death before 34 weeks' gestation. Analysis was by intention to treat. Additionally we undertook a meta-analysis of published and unpublished data to establish the efficacy of progesterone in prevention of early (<34 weeks' gestation) preterm birth or intrauterine death in women with twin pregnancy. This study is registered, number ISRCTN35782581. Findings Three participants in each group were lost to follow-up, leaving 247 analysed per group. The combined proportion of intrauterine death or delivery before 34 weeks of pregnancy was 24.7% (61/247) in the progesterone group and 19.4% (48/247) in the placebo group (odds ratio [OR] 1.36, 95% CI 0.89-2.09; p=0.16). The rate of adverse events did not differ between the two groups. The meta-analysis confirmed that progesterone does not prevent early preterm birth in women with twin pregnancy (pooled OR 1.16, 95% Cl 0.89-1.51). Interpretation Progesterone, administered vaginally, does not prevent preterm birth in women with twin pregnancy.
引用
收藏
页码:2034 / 2040
页数:7
相关论文
共 15 条
[1]   Prevention of Preterm Birth in Triplets Using 17 Alpha-Hydroxyprogesterone Caproate A Randomized Controlled Trial [J].
Caritis, Steve N. ;
Rouse, Dwight J. ;
Peaceman, Alan M. ;
Sciscione, Anthony ;
Momirova, Valerija ;
Spong, Catherine Y. ;
Iams, Jay D. ;
Wapner, Ronald J. ;
Varner, Michael ;
Carpenter, Marshall ;
Lo, Julie ;
Thorp, John ;
Mercer, Brian M. ;
Sorokin, Yoram ;
Harper, Margaret ;
Ramin, Susan ;
Anderson, Garland .
OBSTETRICS AND GYNECOLOGY, 2009, 113 (02) :285-292
[2]   Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: A randomized placebo-controlled double-blind study [J].
da Fonseca, EB ;
Bittar, RE ;
Carvalho, MHB ;
Zugaib, M .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2003, 188 (02) :419-424
[3]   Progesterone supplementation for preventing preterm birth: a systematic review and meta-analysis [J].
Dodd, JM ;
Crowther, CA ;
Cincotta, R ;
Flenady, V ;
Robinson, JS .
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2005, 84 (06) :526-533
[4]   Progesterone for the prevention of preterm birth - A systematic review [J].
Dodd, Jodie M. ;
Flenady, Vicki J. ;
Cincotta, Robert ;
Crowther, Caroline A. .
OBSTETRICS AND GYNECOLOGY, 2008, 112 (01) :127-134
[5]   Progesterone and the risk of preterm birth among women with a short cervix [J].
Fonseca, Eduardo B. ;
Celik, Ebru ;
Parra, Mauro ;
Singh, Mandeep ;
Nicolaides, Kypros H. ;
Thornton, S. ;
Alfirevic, Z. ;
Smith, G. ;
Radhakrishnan, P. ;
Khoury, O. ;
Divianathan, L. ;
Kaul, A. ;
Rao, A. ;
Kuppusamy, R. ;
Molina, F. ;
Turan, S. ;
Gajewska, K. ;
Palanappian, V. ;
Paramasivam, G. ;
Atzei, A. ;
Poggi, S. ;
Vafaie, H. ;
Hagan, P. ;
Coward, H. ;
Milovanovic, Z. ;
Nikolopoulou, D. ;
Tsolakidis, F. ;
Rencoret, G. ;
Pedraza, D. ;
Valdes, E. ;
Valadares, S. ;
Damiao, R. ;
Skentou, H. .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (05) :462-469
[6]   Young adult outcomes of very-low-birth-weight children [J].
Hack, M .
SEMINARS IN FETAL & NEONATAL MEDICINE, 2006, 11 (02) :127-137
[7]  
HARTIKAINENSORRI AL, 1980, OBSTET GYNECOL, V56, P692
[8]   Economic implications of multiple births: inpatient hospital costs in the first 5 years of life [J].
Henderson, J ;
Hockley, C ;
Petrou, S ;
Goldacre, M ;
Davidson, L .
ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION, 2004, 89 (06) :F542-F545
[9]  
*INF SERV DIV NHS, 2007, SCOTT PROGR CLIN EFF
[10]  
*INF SERV DIV NHS, 2008, BIRTHS BAB